share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股sec公告 ·  06/17 21:45
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on June 14, 2024. The specific details of the transaction, including the number of shares involved and the transaction price, were not disclosed in the announcement. As the head of the pharmaceutical giant, Bourla's financial moves are closely watched by investors for indications of his confidence in the company's performance and prospects. The absence of detailed transaction data in the report leaves the impact of this event on Pfizer's stock somewhat unclear to shareholders and potential investors.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on June 14, 2024. The specific details of the transaction, including the number of shares involved and the transaction price, were not disclosed in the announcement. As the head of the pharmaceutical giant, Bourla's financial moves are closely watched by investors for indications of his confidence in the company's performance and prospects. The absence of detailed transaction data in the report leaves the impact of this event on Pfizer's stock somewhat unclear to shareholders and potential investors.
辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布尔拉于2024年6月14日执行了一项交易。公告中没有透露交易涉及的股份数量和交易价格的具体细节。作为这家药品巨头的负责人,布尔拉的财务举动受到投资者的密切关注,以判断他对公司业绩和前景的信恳智能。报告中未提供详细的交易数据,使得这一事件对辉瑞股票的影响对股东和潜在投资者而言有些不明确。
辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布尔拉于2024年6月14日执行了一项交易。公告中没有透露交易涉及的股份数量和交易价格的具体细节。作为这家药品巨头的负责人,布尔拉的财务举动受到投资者的密切关注,以判断他对公司业绩和前景的信恳智能。报告中未提供详细的交易数据,使得这一事件对辉瑞股票的影响对股东和潜在投资者而言有些不明确。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息